Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 1;13(6):772-781.
doi: 10.7150/ijbs.19603. eCollection 2017.

Angiomotin Family Members: Oncogenes or Tumor Suppressors?

Affiliations
Review

Angiomotin Family Members: Oncogenes or Tumor Suppressors?

Meng Lv et al. Int J Biol Sci. .

Abstract

Angiomotin (Amot) family contains three members: Amot (p80 and p130 isoforms), Amot-like protein 1 (Amotl1), and Amot-like protein 2 (Amotl2). Amot proteins play an important role in tube formation and migration of endothelial cells and the regulation of tight junctions, polarity, and epithelial-mesenchymal transition in epithelial cells. Moreover, these proteins regulate the proliferation and migration of cancer cells. In most cancers, Amot family members promote the proliferation and invasion of cancer cells, including breast cancer, osteosarcoma, colon cancer, prostate cancer, head and neck squamous cell carcinoma, cervical cancer, liver cancer, and renal cell cancer. However, in glioblastoma, ovarian cancer, and lung cancer, Amot inhibits the growth of cancer cells. In addition, there are controversies on the regulation of Yes-associated protein (YAP) by Amot. Amot promotes either the internalization of YAP into the nucleus or the retention of YAP in the cytoplasm of different cell types. Moreover, Amot regulates the AMPK, mTOR, Wnt, and MAPK signaling pathways. However, it is unclear whether Amot is an oncogene or a tumor suppressor gene in different cellular processes. This review focuses on the multifunctional roles of Amot in cancers.

Keywords: Angiomotin; YAP.; cancer; oncogene; tumor suppressor.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Domain structures of proteins from the Amot family (Amot-p80, Amot-p130, Amotl1, and Amotl2).
Figure 2
Figure 2
Schematic models for YAP regulation by Amot. (A). Amot-p130 facilitates the nuclear entry and transcriptional activity of YAP, promoting the transcription of TEAD-target genes. (B) Amot binds to Merlin at the tight junctions and phosphorylates Mst1/2, LATS1/2, and Mob1. Phosphorylated LATS1/2 phosphorylates YAP, which promotes the ubiquitination and degradation of YAP. (C) Amot promotes the phosphorylation of YAP by LATS2 in the cytoplasm, leading to YAP degradation. (D) LATS-mediated phosphorylation of Amot promotes the interaction between Amot and YAP and subsequent degradation of YAP. (E) F-actin and YAP compete for binding to Amot at the tight junctions. Amot binds to YAP and maintains in the cytoplasm. (F) Amot physically interacts with YAP leading to localization to the actin cytoskeleton.

Similar articles

Cited by

References

    1. Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Van Meir EG. et al. Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene. 2002;298:69–77. - PubMed
    1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364. - PubMed
    1. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Cao Y. et al. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harbor symposia on quantitative biology. 1994;59:471–482. - PubMed
    1. Ji WR, Castellino FJ, Chang Y, Deford ME, Gray H, Villarreal X. et al. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1998;12:1731–1738. - PubMed
    1. Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC. et al. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Science signaling. 2013;6:ra77. - PMC - PubMed

MeSH terms